CClinicalTrials.gg
RecruitingNCT06515717ExoKetUpdated Jul 29, 2024

Exogenous Ketones and Behavior

An interventional study of ketone ester and dextrose (placebo) in Behavior, sponsored by German Institute of Human Nutrition. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-29.

Sponsored by German Institute of Human Nutrition · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The study will examine the effect of exogenous ketone ester on behavior and metabolism using Virtual Reality and computerizes behavioral tasks.

Read the detailed description

This study investigates the effects of exogenous ketone ester on behavior, cognition, and metabolism over one week of consumption. Using a within-subjects, randomized, crossover design, participants will undergo two phases: one with the ketone ester supplement and one with a calorie- and taste-matched placebo. The study includes four lab visits: visits 1 and 3 mark the first day of each intervention, while visits 2 and 4 mark the last day. During each visit, participants will complete behavioral tasks, questionnaires, and blood tests. Additionally, participants will record their food intake via an app and collect stool samples throughout the intervention.

02

Conditions studied

  • Behavior

Keywords

  • ketones
  • human cognition
  • metabolism
  • anxiety
  • intervention
03

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Consent to participate
  • Fluent in German
  • Physically healthy. No regular medication
  • No drug use 1 week prior to the study
  • BMI 18-31 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Former or current illnesses of:
  • Brain or mind (including eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache; depression or anxiety disorder excluded)
  • Heart or blood circulation
  • Gastro-intestinal or endocrine disorders
  • Liver or kidney disorders
  • Electrolyte imbalance
  • Other serious past or present medical conditions (for example, metabolic syndrome, diabetes, cancer)
  • Pregnancy
  • Extreme athletes (>2h/day intense work-out; casual cycling or walking is ok)
  • Menopause (post menopause is ok)
  • Ketogenic diet, ketogenic supplement intake, intermittent fasting or calorie restricted diet during preceding 4 weeks of study participation
  • Fear of blood draw
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    ketone ester

    Participants consume a ketone ester 3x per day for 8 days.

    Dietary Supplement: ketone ester

  • Placebo comparator
    Placebo containing dextrose

    Participants consume a placebo 3x per day for 8 days. The placebo is matched in calories and taste to the ketone ester.

    Dietary Supplement: dextrose (placebo)

Interventions

  • Dietary supplementketone ester

    oral supplement

  • Dietary supplementdextrose (placebo)

    oral supplement calorie and taste matched to ketone supplement

05

What researchers measure

Primary outcomes

  1. Anxiety behavior in Virtual Reality

    Using different scenes in Virtual Reality, parameters of motion behavior such as speed (measured in meters per second) and distance walked (measured in meters) will be assessed using motion tracking technology. These measurements will be combined to generate a composite score of anxiety-related motion behavior.

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  2. Risk propensity on a decision-making task

    The choice (accept/reject) between a risk/gamble or safe option, based on a task paradigm by Liu et al. (2021)

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  3. Competitive confidence in a competition task

    based on a task paradigm by Goette et al., 2015

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  4. Delay Discounting behavior in a computerized task

    based on a task paradigm by Eisenstein et al. 2015

    Time frame: on day 1 of each intervention arm (visit 1 and 3)

  5. Performance in Dual Task

    based on a task paradigm by Szameitat et al., 2002

    Time frame: on day 1 of each intervention arm (visit 1 and 3)

  6. Levels of ketones (ß-Hydroxybutyrate)

    Blood samples

    Time frame: baseline, 15, 30, 60, and 90 minutes post drink-consumption on each of the 4 visits

  7. Insulin

    Blood samples

    Time frame: baseline, 15, 30, 60, and 90 minutes post drink-consumption on each of the 4 visits

  8. Ghrelin

    Blood samples

    Time frame: baseline and + 90 minutes post drink-consumption on each of the 4 visits

  9. Glucose Values

    Continuous Glucose Monitoring through sensors applied to skin

    Time frame: every 15 Minutes from visit 1 to visit 2 and again from visit 3 to visit 4

  10. Blood Glucose

    Blood samples

    Time frame: baseline, 15, 30, 60, and 90 minutes post drink-consumption on each of the 4 visits

  11. Levels of cortisol

    Blood samples

    Time frame: baseline, 15, 30, 60, and 90 minutes post drink-consumption on each of the 4 visits

  12. Electrocardiogram (heart rate)

    Electrophysiological recording

    Time frame: between 30 and 60 minutes post drink-consumption on each of the 4 visits

  13. Electrocardiogram (heart rate variability)

    Electrophysiological recordings

    Time frame: between 30 and 60 minutes post drink-consumption on each of the 4 visits

  14. Electrodermal Activity

    Electrophysiological recordings

    Time frame: between 30 and 60 minutes post drink-consumption on each of the 4 visits

  15. Subjective anxiety levels

    reported by participants on visual analog scale (1-7) during Virtual Reality. 1 being no anxiety to 7 being high anxiety

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  16. Subjective stress levels

    reported by participants on visual analog scale (1-7) during Virtual Reality. 1 being no stress to 7 being high stress

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

Secondary outcomes

  1. Gut microbiome

    Assessed via stool samples after each intervention

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  2. Daily food intake

    Self-reported food intake recorded via FoodApp or handwritten food diary

    Time frame: 5 days of each intervention arm

  3. Trait Anxiety Questionnaire

    Trait version of State-Trait Anxiety Inventory (STAI; Grimm et al. 2009). High scores mean high trait anxiety.

    Time frame: baseline before visit 1

  4. State Anxiety Questionnaire

    State version of State-Trait Anxiety Inventory (STAI; Grimm et al. 2009). High scores mean high state anxiety.

    Time frame: on day 1 and 8 of each intervention arm (visit 1,2,3,4)

  5. Interoception Questionnaire

    Multidimensional Assessment of Interoceptive Awareness (MAIA; Bornemann et al. 2015). High scores mean high interoceptive ability.

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  6. Depression Questionnaire

    Becks Depression Inventar (BDI; Kühner et al. 2007). High scores mean high depression scores

    Time frame: baseline, and on day 8 of each intervention arm (visit 1, 2, and 4)

  7. Mood Questionnaire

    Positive and Negative Affect Schedule (PANAS; Janke et al. 2014). High score on positive scale mean high positive mood and high scores on negative scale mean high negative mood.

    Time frame: on day 1 and 8 of each intervention arm (visit 1,2,3,4)

  8. Inhibition Questionnaire

    Behavioral Inhibition and Activation (BISBAS; Strobel et al. 2001). High scores on inhibition scale mean high inhibition and high scores on activation scale mean high activation.

    Time frame: baseline (visit 1)

  9. Impulsivity Questionnaire

    Barratt Impulsiveness Scale (BIS; Barratt et al. 1965). High scores mean high impulsivity.

    Time frame: baseline (visit 1)

  10. Social Anxiety Questionnaire

    Liebowitz Social Anxiety Scale (Heimberg et al. 1999). High scores mean high scoial anxiety

    Time frame: baseline, and on day 8 of each intervention arm (visit 1, 2, and 4)

  11. Flow Questionnaire

    Flow state scale (FSS; Rheinberg et al. 2002) asked after Dual Task. High scores mean more flow experience during the dual task.

    Time frame: on day 1 of each intervention arm (visit 1 and 3)

  12. Emotional Eating Questionnaire

    Salzburg Emotional Eating Scale (SEES; Meule et al. 2018)

    Time frame: baseline (visit 1)

  13. Stress Eating Questionnaire

    Salzburg Stress Eating Scale (SSES; Meule et al. 2018)

    Time frame: baseline (visit 1)

  14. Dominance Questionnaire

    Social Dominance and Aggressive Dominance Scale (Kalma et al. 1993)

    Time frame: baseline, and on day 8 of each intervention arm (visit 1, 2, and 4)

  15. Autonomy Questionnaire

    Basic Psychological Need Satisfaction and Frustration Scale (BPNSNF; Heissel et al. 2019)

    Time frame: on day 8 of each intervention arm (visit 2 and 4)

  16. Personality Questionnaire

    Big Five Inventory (BFI; John et al. 1991)

    Time frame: baseline (visit 1)

  17. Chronotype Questionnaire

    Morningness-Eveningness Questionnaire (MEQ; Horne \& Östberg, 1976)

    Time frame: baseline (visit 1)

  18. Stress Questionnaire

    Perceived Stress Questionnaire (PSQ; Fliege et al. 2001)

    Time frame: baseline, and on day 8 of each intervention arm (visit 1, 2, and 4)

  19. Subjective anxiety levels

    reported via FoodApp once per day

    Time frame: 5 days of each intervention arm

  20. Subjective stress levels

    reported via FoodApp once per day

    Time frame: 5 days of each intervention arm

06

Study locations

1 of 1 sites recruiting
  • German Institute of Human Nutrition
    Potsdam, Brandenburg 14558, Germany
    Recruiting
07

References and documents

Publications

  • Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbelaez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS One. 2016 Jan 8;11(1):e0147063. doi: 10.1371/journal.pone.0147063. eCollection 2016. No abstract available. PubMed 26744894 ↗
  • Goette L, Bendahan S, Thoresen J, Hollis F, Sandi C. Stress pulls us apart: anxiety leads to differences in competitive confidence under stress. Psychoneuroendocrinology. 2015 Apr;54:115-23. doi: 10.1016/j.psyneuen.2015.01.019. Epub 2015 Feb 19. PubMed 25705012 ↗
  • Liu L, Artigas SO, Ulrich A, Tardu J, Mohr PNC, Wilms B, Koletzko B, Schmid SM, Park SQ. Eating to dare - Nutrition impacts human risky decision and related brain function. Neuroimage. 2021 Jun;233:117951. doi: 10.1016/j.neuroimage.2021.117951. Epub 2021 Mar 12. PubMed 33722669 ↗

Individual participant data

Plan to share: Yes

08

Registry details

Key details

Study ID
NCT06515717
Lead sponsor
German Institute of Human Nutrition
Responsible party
Prof. Dr. Soyoung Q Park (Prof. Dr., German Institute of Human Nutrition) — Principal investigator
First posted
Jul 23, 2024
Start date
Jul 18, 2024 (estimated)
Primary completion
Jun 23, 2025 (estimated)
Completion
Jun 23, 2025 (estimated)
Last update
Jul 29, 2024

Study contacts

Beatrix Keweloh
Contact
Beatrix.Keweloh@dife.de
+49 33200 882518
Soyoung Q Park, Prof.
Contact
Soyoung.Park@dife.de

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion